Myriad Genetics Signs Agreement with Nationally Renowned Sports Broadcaster Hannah Storm to Promote the Importance of Knowing Family Cancer History
Portfolio Pulse from
Myriad Genetics has partnered with sports broadcaster Hannah Storm to promote their Breast Cancer Risk Assessment Program. Storm, who has battled breast cancer, will serve as an ambassador for Myriad's MyRisk® with RiskScore® Hereditary Cancer Test.
January 09, 2025 | 9:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Myriad Genetics has signed an agreement with Hannah Storm to promote their Breast Cancer Risk Assessment Program, potentially increasing brand visibility and product adoption.
The partnership with a high-profile figure like Hannah Storm is likely to enhance Myriad Genetics' brand visibility and credibility, potentially leading to increased adoption of their MyRisk® with RiskScore® test. This could positively impact MYGN's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90